• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 15, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

George & Matilda expands audiology offering with Audeara deal

by Staff Writer
March 12, 2025
in Company updates & acquisitions, Local, News, Ophthalmic insights
Reading Time: 3 mins read
A A
The deal broadens Audeara’s existing 1,500-clinic footprint in Australia where its products are sold. Images: George & Matilda & Pormezz/stock.adobe.com.

The deal broadens Audeara’s existing 1,500-clinic footprint in Australia where its products are sold. Images: George & Matilda & Pormezz/stock.adobe.com.

Share on FacebookShare on Twitter

Optometry provider George & Matilda Eyecare (G&M), which began rolling out audiology services within its network almost two years ago, has penned an agreement to stock Audeara listening devices designed and engineered in Australia.

An ASX announcement from Audeara said it secured a reseller agreement with G&M, allowing the former’s range of tailored audio solutions to be offered through the optometry-audiology group’s store network.

Since it was established in 2016, G&M has grown to 115 practices which service 140 communities across Australia. Audiology was added as a new allied health stream for the group in mid-2023 and has been introduced to subsequent locations.

The goal is to have audiology available across the entire network, CEO Mr Chris Beer has previously told Insight. In cases where a dedicated audiology space isn’t feasible, the practice will offer screening and refer patients to another G&M practice with full audiology services.

As part of the Audeara agreement, G&M will offer Audeara’s branded assistive listening devices to customers “to highlight how personalised audio solutions complement the effectiveness of tailored optical care”, reinforcing the “importance of individualised sensory health”.

G&M will initially stock the recently launched Audeara Buds product, with an aim to broaden to Audeara’s full suite of audiology solutions for patients who may not yet require hearing aids.

Audeara Buds are described as the company’s first in-ear solution, designed with advanced, AI-driven hearing health technology and user-centric innovation.

Audeara expects first sales from G&M stores in the coming weeks, with the agreement broadening Audeara’s existing 1,500-clinic footprint in Australia.

About the deal, Beer said G&M was excited to collaborate with Audeara and add its assisted listening device solutions to its “existing range of world class hearing aids”.

“Our goal has always been to provide the best optical and audiology care to our patients and now we are extending this care to additional patients with a high calibre partner in Audeara,” he said.

Audeara sells its products through distributors and resellers in Australia, Europe, Asia and North America, and through e-commerce channels.

The company’s CEO and managing director Dr James Fielding said G&M was one of the most trusted names in the Australian eye health and optical retail segment.

“Their reputation, Australian market footprint and our innovative audio technology has the potential to reach a broad customer base, who are expected to considerably benefit from [our] solutions,” he said.

“Importantly, this agreement will unlock another sales channel in the Australian market for the company’s hardware products and build on our established footprint of 1,500 clinics. We look forward to working alongside the group’s personnel to educate them on our solutions in the coming weeks.”

More reading

George & Matilda’s optometry-audiology integration blueprint

Chris Beer unplugged on the future of George & Matilda optometry network

George & Matilda acquires National Optical Care network

Related Posts

The capsule collection draws from Carrera’s historic colours – black, white and red. Image: Carrera.

Carrera celebrates milestone with limited-edition collection

by Rob Mitchell
July 14, 2026

To celebrate its 70th anniversary, Carrera has announced the introduction of an exclusive Made in Italy limited-edition capsule collection that...

Vision Eye Institute CEO Amanda Cranage (right) at Vision Hospital Group’s Boroondara Day Surgery. Images: VEI.

The hidden drivers of cataract success

by Helen Carter
July 14, 2026

It’s not just what happens under the surgical microscope that leads to strong cataract surgery outcomes. Many gains come from...

The runway concept evolved from a desire to reinvent a long-standing feature on the trade floor. Images: ODMA.

Runway spectacle for O-SHOW26

by Helen Carter
July 13, 2026

O-SHOW26 will turn up the fashion focus with its first ever runway parades to showcase frames in August. Event manager...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited